Skip to content

Comparison of Electrotherapy and intralesional injection of Glucantime in the treatment of Coetaneous Leishmaniasis

Clinical trial of comparison of Electrotherapy and intralesional injection of Glucantime in the treatment duration of Coetaneous Leishmaniasis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016011822583N3
Enrollment
60
Registered
2016-02-28
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous Leishmaniasis. Cutaneous leishmaniasis

Interventions

Intervention 1: The Electrotherapy was performed in the intervention group once per week.The lesion was received an electric current with 40 volts and 5-15 ampere for 10 minutes. Intervention 2: In th
Treatment - Other
Treatment - Drugs
The Electrotherapy was performed in the intervention group once per week.The lesion was received an electric current with 40 volts and 5-15 ampere for 10 minutes.
In the control group, Glucantime ampoule(5ml) were injected intralesional, twice a week and was continued until around the lesion was white.

Sponsors

Vice Chancellor for research of North Khorasan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: the lack of local or systemic treatment for Cutaneous Leishmaniasis; the appearance of skin lesions is less than 12 weeks ego. Exclusion criteria: age less than 2 years; previous history of Cutaneous Leishmaniasis; pregnant or lactating women; malnutrition and underlying severe disease; contraindications for drug administration.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Size of lesion. Timepoint: Once a week. Method of measurement: Ruler.;Recovery time. Timepoint: Once a week. Method of measurement: Clinical observation.

Secondary

MeasureTime frame
Inflammation. Timepoint: Once a week. Method of measurement: Clinical observation.;Blisters around the lesion. Timepoint: Once a week. Method of measurement: Clinical observation.;Secretion of the lesion. Timepoint: Once a week. Method of measurement: Clinical observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Shoja

Esfarayen faculty of Medical Sciences

mohsenshoja61@yahoo.com+98 58 3724 1601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026